{"uid":"cap_AhzMqdt1gePMC3Otiy2vD","slug":"us-pharma-earnings-ai-interpretation-api-02ccb79b","name":"US Pharma Earnings & AI Interpretation API","description":"美股医药健康财报+AI解读 — 6家美股医药巨头(礼来/强生/联合健康/默沙东/辉瑞/艾伯维): 最新季营收净利与同比(SEC官方XBRL), 中文AI解读, 板块景气概览。","url":"https://agentdatum.com/api/v1/d/us-earnings-pharma","method":"GET","headers":{},"bodySchema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","required":[],"properties":{}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}},"responseSchema":null,"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.01","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.01/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.01","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.01","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_SjqGvkVH2tekQ9gvlLp9q","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.01","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns latest quarterly revenue and net income (with YoY comparisons) for 6 major US pharmaceutical giants, sourced from SEC official XBRL filings, with Chinese-language AI commentary and sector health overview.","exampleAgentPrompt":"Can you pull the latest quarterly earnings for the top US pharma companies — Eli Lilly, J&J, UnitedHealth, Merck, Pfizer, and AbbVie — with revenue, net income, year-over-year changes from SEC filings, and an AI summary of how the sector is doing?","exampleUseCases":[{"title":"Pharma sector earnings briefing","prompt":"Give me a quick briefing on how the major US pharma stocks — Eli Lilly, Pfizer, Merck, J&J, AbbVie, and UnitedHealth — did last quarter, including revenue, net income, and whether they're up or down year-over-year."},{"title":"Chinese-language investment research report","prompt":"我需要六大美股医药巨头（礼来、强生、联合健康、默沙东、辉瑞、艾伯维）的最新季度财报数据，包括营收、净利润和同比变化，以及AI对板块整体景气度的中文解读。"},{"title":"Portfolio monitoring for pharma holdings","prompt":"I hold positions in Pfizer, AbbVie, and Eli Lilly — can you get me their latest quarterly revenue and net income figures from SEC filings so I can see how my pharma holdings are performing?"}],"resultDescription":"Returns structured financial data for 6 US pharma companies (Eli Lilly, Johnson & Johnson, UnitedHealth, Merck, Pfizer, AbbVie) including: latest quarterly revenue, net income, year-over-year percentage changes sourced from SEC official XBRL data, a Chinese-language AI interpretation of each company's results, and a sector-level health/sentiment overview.","failureModes":["SEC XBRL data may be delayed if filings are not yet submitted by the companies","Payment via x402 protocol may fail if USDC balance is insufficient (0.01 USDC required per call)","Response may be stale if called between earnings seasons when no new data is available","API may return partial data if one or more companies have not yet filed their latest quarterly report"],"whenToPreferThis":"Choose this endpoint when you need a single aggregated call covering all 6 major US pharma giants' latest SEC-sourced earnings with AI interpretation, particularly when your workflow targets Chinese-language financial analysis or needs sector-level commentary alongside raw numbers. Prefer this over general financial data APIs when you specifically want XBRL-sourced SEC official data with AI-generated sector narrative in Chinese.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-15T01:05:40.011Z","isFirstParty":false}